Kumar Neil sold BBIO
August 16, 2025 · Form 4 insider transaction
Kumar Neil sold 33,544 shares of BridgeBio Pharma, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Disposed (sell-side)
Shares
33,544
Price
$0.00
Total value
N/A
InsiderKumar Neil
RoleOfficer, Director
SecurityRestricted Stock Units
Transaction codeM: Option exercise
Transaction dateAugust 16, 2025
Filing dateAugust 19, 2025
Shares owned after201,264
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.; The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2023. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.